A Study to Evaluate the Safety and Efficacy of Dasatinib (Sprycel) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Clinical trial NCT00918463 · TERMINATED
Trial details
- NCT number
- NCT00918463
- Sponsor
- Weill Medical College of Cornell University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2010-12-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.